Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 13 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 10465004

    Frizzled receptor antibodies for treatment of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted

  2. US 10463685

    Telomerase mediated telomere altering compounds

    The Board of Regents of the University of Texas System · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted

  3. US 10456404

    Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  4. US 10456461

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  5. US 10435695

    Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  6. US 10426767

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncolofy, Inc. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  7. US 10420758

    Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  8. US 10420769

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  9. US 10414725

    Pyrrolomycins and methods of using the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  10. US 10406158

    Methods and compositions for treating abnormal cell growth

    VERASTEM, INC. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  11. US 10398772

    Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  12. US 10363282

    Analogs of C5a and methods of using same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  13. US 10342771

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  14. US 10335478

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  15. US 10335368

    Ultrasound-triggerable agents for tissue engineering

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  16. US 10335404

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  17. IL 265680

    Dimeric contrast agents

    BRACCO IMAGING SPA [IT] · Granted May 30, 2019 · Expires May 25, 2039

    granted

  18. US 10292979

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  19. US 10278976

    Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors

    MIRA DX, INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  20. US 10265412

    Enzyme replacement therapy for treating lysosomal storage diseases

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  21. US 10266579

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  22. US 10253039

    Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  23. AU 2017305856

    Pharmaceutical formulations of C1 esterase inhibitor

    CSL BEHRING GMBH [DE] · Granted Mar 21, 2019 · Expires Mar 16, 2039

    granted

  24. US 10226468

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.